Literature DB >> 26590105

MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.

Keiichi Haga1,2, Asako Chiba1, Tomoyoshi Shibuya2, Taro Osada2, Dai Ishikawa2, Tomohiro Kodani2, Osamu Nomura2, Sumio Watanabe2, Sachiko Miyake1.   

Abstract

BACKGROUND AND AIM: Ulcerative colitis (UC) is a chronic, relapsing and remitting, inflammatory disorder of the large intestine. Mucosal associated invariant T (MAIT) cells are a member of innate-like lymphocytes found abundantly in the mucosal tissue. The contribution of MAIT cells in the pathogenesis of UC is still unclear; therefore, this study aimed at investigating the role of these cells in patients with UC.
METHODS: The frequency of MAIT cells, as well as the production of cytokines and expression levels of activation markers by these cells in the peripheral blood of UC patients and healthy controls, was analyzed by flow cytometry. MAIT cells were also quantified in colon biopsies of UC patients using a confocal microscope.
RESULTS: There was a significant reduction in MAIT cell frequency in the peripheral blood of UC patients compared with healthy controls (P < 0.0001). MAIT cells from UC patients secreted more interleukin (IL)-17 than healthy controls (P < 0.05). The expression levels of CD69 on these cells were correlated with disease activity and endoscopic scores and plasma levels of IL-18. Furthermore, MAIT cells increased in the inflamed mucosa, and their frequency was correlated with clinical and endoscopic disease activity in UC patients.
CONCLUSIONS: The findings from this study indicate that MAIT cells could be associated with UC and may serve as potential biomarkers or therapeutic targets in UC.
© 2015 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  MAIT cells; activation marker; inflammatory bowel diseases; ulcerative colitis

Mesh:

Substances:

Year:  2016        PMID: 26590105     DOI: 10.1111/jgh.13242

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  41 in total

1.  Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells.

Authors:  Joana Dias; Julia Hengst; Tiphaine Parrot; Edwin Leeansyah; Sebastian Lunemann; David F G Malone; Svenja Hardtke; Otto Strauss; Christine L Zimmer; Lena Berglin; Thomas Schirdewahn; Sandra Ciesek; Nicole Marquardt; Thomas von Hahn; Michael P Manns; Markus Cornberg; Hans-Gustaf Ljunggren; Heiner Wedemeyer; Johan K Sandberg; Niklas K Björkström
Journal:  J Hepatol       Date:  2019-05-14       Impact factor: 25.083

2.  Human Tissue-Resident Mucosal-Associated Invariant T (MAIT) Cells in Renal Fibrosis and CKD.

Authors:  Becker M P Law; Ray Wilkinson; Xiangju Wang; Katrina Kildey; Kurt Giuliani; Kenneth W Beagley; Jacobus Ungerer; Helen Healy; Andrew J Kassianos
Journal:  J Am Soc Nephrol       Date:  2019-06-11       Impact factor: 10.121

Review 3.  Old and New Lymphocyte Players in Inflammatory Bowel Disease.

Authors:  Paolo Giuffrida; Gino Roberto Corazza; Antonio Di Sabatino
Journal:  Dig Dis Sci       Date:  2017-12-23       Impact factor: 3.199

Review 4.  MR1-dependent antigen presentation.

Authors:  Elham Karamooz; Melanie J Harriff; David M Lewinsohn
Journal:  Semin Cell Dev Biol       Date:  2018-12       Impact factor: 7.727

5.  Mucosal-associated invariant T cells are activated in an interleukin-18-dependent manner in Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.

Authors:  Yuriko Ishikawa; Masaki Yamada; Naomi Wada; Etsuko Takahashi; Ken-Ichi Imadome
Journal:  Clin Exp Immunol       Date:  2022-04-04       Impact factor: 4.330

Review 6.  MAIT cells and microbial immunity.

Authors:  Erin W Meermeier; Melanie J Harriff; Elham Karamooz; David M Lewinsohn
Journal:  Immunol Cell Biol       Date:  2018-03-09       Impact factor: 5.126

7.  Activation, Deficiency, and Reduced IFN-γ Production of Mucosal-Associated Invariant T Cells in Patients with Inflammatory Bowel Disease.

Authors:  Jae Kyun Ju; Young-Nan Cho; Ki-Jeong Park; Han Deok Kwak; Hye-Mi Jin; Seon-Young Park; Hyun Soo Kim; Seung-Jung Kee; Yong-Wook Park
Journal:  J Innate Immun       Date:  2020-06-12       Impact factor: 7.349

Review 8.  Barrier lymphocytes in spondyloarthritis.

Authors:  Adam Berlinberg; Kristine A Kuhn
Journal:  Curr Opin Rheumatol       Date:  2020-07       Impact factor: 5.006

Review 9.  Using single cell analysis for translational studies in immune mediated diseases: Opportunities and challenges.

Authors:  Siddhartha Sharma; Louis Gioia; Brian Abe; Marie Holt; Anne Costanzo; Lisa Kain; Andrew Su; Luc Teyton
Journal:  Mol Immunol       Date:  2018-10-06       Impact factor: 4.407

Review 10.  Mucosal-associated invariant T cells and disease.

Authors:  Amine Toubal; Isabelle Nel; Sophie Lotersztajn; Agnès Lehuen
Journal:  Nat Rev Immunol       Date:  2019-10       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.